Loading…
CIK 0001910456 • 7 13F filings • May 15, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("lynx1-capital-management-lp","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS INC | COM | $2.2M | 0.4% | 79,624 SH | New |
| APPLIED THERAPEUTICS INC | COM | $41K | 0.0% | 410,500 SH | New |
| ARROWHEAD PHARMACEUTICALS IN | COM | $800K | 0.2% | 12,043 SH | New |
| C4 THERAPEUTICS INC | COM STK | $13.6M | 2.7%Prev: 3.2% | 7,098,133 SH | Decreased |
| CG ONCOLOGY INC | COM | $1.3M | 0.3% | 31,591 SH | New |
| CULLINAN THERAPEUTICS INC | COM | $92.8M | 18.8%Prev: 7.0% | 8,963,500 SH | Increased+3,197,410 SH |
| DENALI THERAPEUTICS INC | COM | $28.7M | 5.8%Prev: 0.8% | 1,738,750 SH | Increased+1,477,063 SH |
| DESIGN THERAPEUTICS INC | COM | $652K | 0.1%Prev: 0.1% | 69,516 SH | Increased+3,562 SH |
| ENTRADA THERAPEUTICS INC | COM | $531K | 0.1% | 51,689 SH | New |
| GENERATION BIO CO | COM NEW | $142K | 0.0% | 25,000 SH | New |
| GH RESEARCH PLC | ORDINARY SHARES | $132.2M | 26.8%Prev: 21.2% | 10,406,575 SH | Increased+1,805,386 SH |
| IMMATICS N.V | SHS | $9.7M | 2.0% | 921,950 SH | New |
| KORRO BIO INC | COM | $5.4M | 1.1% | 677,915 SH | New |
| MAPLIGHT THERAPEUTICS INC | COM | $237K | 0.0% | 13,477 SH | New |
| NEUPHORIA THERAPEUTICS INC | COM | $3.4M | 0.7% | 875,228 SH | New |
| PASSAGE BIO INC | COM NEW | $7.4M | 1.5%Prev: 1.0% | 623,704 SH | Increased |
| PRECISION BIOSCIENCES INC | COM NEW | $4.1M | 0.8%Prev: 1.2% | 993,913 SH | Decreased-48,683 SH |
| PROQR THRAPEUTICS N V | SHS EURO | $138K | 0.0% | 68,486 SH | New |
| STOKE THERAPEUTICS INC | COM | $171.5M | 34.7%Prev: 22.4% | 5,404,674 SH | Increased |
| TSCAN THERAPEUTICS INC | COM | $8.0M | 1.6%Prev: 2.9% | 8,019,148 SH | Decreased+161,801 SH |
| WEREWOLF THERAPEUTICS INC | COM | $416K | 0.1% | 655,926 SH | New |
| XENCOR INC | COM | $10.8M | 2.2% | 705,558 SH | New |
| 13F-HR/A |
| 0001910456-26-000004 |
| $865.5M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001085146-25-005127 | $346.2M | View |
| May 4, 2026 | Q1 2026 | 13F-HR | 0001910456-26-000002 | $632.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001892688-25-000120 | $279.2M | View |